Human IL11/AGIF/IL-11 ORF/cDNA clone-Adenovirus plasmid (NM_000641)
Cat. No.: pGMAP-IL-097
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IL11/AGIF/IL-11 adenoviral expression plasmid for IL11 adenovirus packaging, IL11 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
IL-11/IL11/IL11/AGIF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAP-IL-097 |
| Gene Name | IL11 |
| Accession Number | NM_000641 |
| Gene ID | 3589 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 600 bp |
| Gene Alias | AGIF,IL-11 |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Kanamycin |
| ORF Nucleotide Sequence | ATGAACTGTGTTTGCCGCCTGGTCCTGGTCGTGCTGAGCCTGTGGCCAGATACAGCTGTCGCCCCTGGGCCACCACCTGGCCCCCCTCGAGTTTCCCCAGACCCTCGGGCCGAGCTGGACAGCACCGTGCTCCTGACCCGCTCTCTCCTGGCGGACACGCGGCAGCTGGCTGCACAGCTGAGGGACAAATTCCCAGCTGACGGGGACCACAACCTGGATTCCCTGCCCACCCTGGCCATGAGTGCGGGGGCACTGGGAGCTCTACAGCTCCCAGGTGTGCTGACAAGGCTGCGAGCGGACCTACTGTCCTACCTGCGGCACGTGCAGTGGCTGCGCCGGGCAGGTGGCTCTTCCCTGAAGACCCTGGAGCCCGAGCTGGGCACCCTGCAGGCCCGACTGGACCGGCTGCTGCGCCGGCTGCAGCTCCTGATGTCCCGCCTGGCCCTGCCCCAGCCACCCCCGGACCCGCCGGCGCCCCCGCTGGCGCCCCCCTCCTCAGCCTGGGGGGGCATCAGGGCCGCCCACGCCATCCTGGGGGGGCTGCACCTGACACTTGACTGGGCCGTGAGGGGACTGCTGCTGCTGAAGACTCGGCTGTGA |
| ORF Protein Sequence | MNCVCRLVLVVLSLWPDTAVAPGPPPGPPRVSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAMSAGALGALQLPGVLTRLRADLLSYLRHVQWLRRAGGSSLKTLEPELGTLQARLDRLLRRLQLLMSRLALPQPPPDPPAPPLAPPSSAWGGIRAAHAILGGLHLTLDWAVRGLLLLKTRL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T56308-Ab | Anti-IL11/ AGIF/ IL-11 functional antibody |
| Target Antigen | GM-Tg-g-T56308-Ag | IL11 protein |
| Cytokine | cks-Tg-g-GM-T56308 | interleukin 11 (IL11) protein & antibody |
| ORF Viral Vector | pGMLP003437 | Human IL11 Lentivirus plasmid |
| ORF Viral Vector | pGMLP-IL-014 | Human IL11 Lentivirus plasmid |
| ORF Viral Vector | pGMAP-IL-097 | Human IL11 Adenovirus plasmid |
| ORF Viral Vector | vGMLP003437 | Human IL11 Lentivirus particle |
| ORF Viral Vector | vGMLP-IL-014 | Human IL11 Lentivirus particle |
| ORF Viral Vector | vGMAP-IL-097 | Human IL11 Adenovirus particle |
Target information
| Target ID | GM-T56308 |
| Target Name | IL-11/IL11 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3589 |
| Gene ID |
100056037 (Equus caballus), 100337295 (Bos taurus), 101085086 (Felis catus), 16156 (Mus musculus) 171040 (Rattus norvegicus), 3589 (Homo sapiens), 611309 (Canis lupus familiaris), 722817 (Macaca mulatta) |
| Gene Symbols & Synonyms | IL11,Il11,IL-11,Il-11,AGIF |
| Target Alternative Names | AGIF,Adipogenesis inhibitory factor (AGIF),IL-11,IL11,Il-11,Il11,Interleukin-11 |
| Uniprot Accession |
P20809,P47873,Q99MF5
Additional SwissProt Accessions: P47873,Q99MF5,P20809 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Rheumatoid arthritis |
| Gene Ensembl | ENSECAG00000014511, ENSBTAG00000057283, ENSMUSG00000004371, ENSG00000095752, ENSCAFG00845000969 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


